RUNX1 stimulated G1 to S progression in hematopoietic cells, partly via transcriptional induction of cyclin D2 promoter [31], whereas RUNX1 depletion resulted in an increased E2F1 mRNA levels in lung cancer cells [10]. Here, CCND2 is linked to lung cancer.